18th Annual CMHC On Demand

The recordings from the 18th Annual meeting are now available. 

There is a registration fee for this activity (if you were a live attendee please refer to the below note). Registration can be found here. Once registration is complete, you will receive a confirmation email with an access code and link back to this course.

If you attended the 2023 annual meeting, please reach out to info@cardiometabolichealth.org and we will provide you with complimentary access code to this activity.

Target Audience

The educational design of this activity addresses the needs of US-based healthcare professionals, including cardiologists, endocrinologists, lipidologists, primary care clinicians (PCPs), registered nurses, advanced practice registered nurses, dieticians, pharmacists, and other allied health professionals involved in the management and treatment of cardiometabolic patients.

Learning Objectives

After completing this activity, the participant should be better able to:

  • Discuss the interrelationships among cardiometabolic risk factors and their impact on the development of cardiometabolic diseases, including diabetes, dyslipidemia, hypertension, obesity, kidney disease, and cardiovascular disease
  • Interpret the latest evidence and guidelines for the prevention, screening, and treatment of the complex patient with cardiometabolic risk or cardiometabolic disease
  • Outline strategies aimed at timely screening and prevention of cardiometabolic disease, including assessment of risk factors and lifestyle modifications
  • Develop individualized treatment regimens for patients with cardiometabolic disease based on the efficacy and safety of current and new pharmacotherapies, patient comorbidities and preferences in order to optimize outcomes
  • Summarize recent evidence for emerging therapies in order to stay current with the most recent updates in the cardiometabolic field
  • Review the role of digital health and technology applications in the prevention and treatment of cardiometabolic risk and disease 
Course summary
Available credit: 
  • 19.25 ACPE Pharmacy
  • 19.25 AMA PRA Category 1 Credit™
  • 19.25 ANCC
  • 19.25 CDE
  • 19.25 Participation
Course opens: 
12/05/2023
Course expires: 
12/05/2024
Rating: 
5

Agenda

Setting the Stage: What Digital Health Means for Clinicians and Patients
Patrick Dunn, PhD

The Role of Digital Health & Technology in Cardiometabolic Risk Reduction: Where We Are and Where Are We Going

Technology & Digital Health in Lifestyle and Obesity

Health and Care Apps for Lifestyle and Obesity: The Importance of Self-Monitoring
Tiffany Powell-Wiley, MD, MPH

Continuous Glucose Monitoring: The New Frontier in Lifestyle Management?
Athena Philis-Tsimikas, MD

Changing Behavior Using Digital Health for Long Term Weight Management
Martin S. Hagger, PhD

Panel Discussion and Audience Q&A
Moderator: Seth Martin, MD, MHS
Panelists: Tiffany Powell-Wiley, MD, MPH; Athena Philis-Tsimikas, MD; Martin S. Hagger, PhD

Technology & Digital Health in Type 2 Diabetes

The Role of CGM in the Management of Type 2 Diabetes: Patient Selection & Important Pearls
Supported by Dexcom.
Grazia Aleppo, MD, FACE, FACP

Insulin Delivery and Insulin Pumps in Patients with Type 2 Diabetes
Viral Shah, MD

Technology & Digital Health in CVD & CVD Risk Reduction

Technology to Close Gaps in Hypertension Care
Daichi Shimbo, MD

Advances in Digital Health for Arrhythmia Management
Mohamed B. Elshazly, MD, MBEE, FACC

Health Technologies for CVD Prevention
Francoise Marvel, MD

Panel Discussion and Audience Q&A
Moderator: Seth Martin, MD, MHS
Panelists: Daichi Shimbo, MD; Mohamed B. Elshazly, MD, MBEE, FACC; Francoise Marvel, MD
 

Technology & Digital Health in Cardiometabolic Health: Discussions & Practical Strategies for Implementation

Discussions & Perspectives: What Role Does Technology and Digital Health Play in Addressing Disparities in Care?
Moderator: Seth Martin, MD, MHS
Panelists: Yvonne Commodore-Mensah, PhD, MHS, RN; Christie M. Ballantyne, MD

How Do Clinicians and Patients Better Use This Data: Challenges and Possible Solutions
Moderator: Seth Martin, MD, MHS
Panelists: Eric D. Peterson, MD, MPH; Francoise Marvel, MD

FDA Updates & Keynote

FDA Update and Late Breaking Trials
Moderator: Christie M. Ballantyne, MD
Presenters: Deepak L. Bhatt, MD; Robert H. Eckel, MD; Keith C. Ferdinand; Anne L. Peters, MD

Keynote Address: Screening for Social Determinants of Cardiometabolic Health & Practice Implications
A. Enrique Caballero, MD

Obesity & Lifestyle

Diving Deeper Into Exercise Regimens for Cardiometabolic Health
Mercedes Carnethon, PhD; Jane Reusch, MD

Debate and Discussion: Is it Time to Compare High-Intensity GLP-1 RAs to Surgery for the Management of Obesity?
Donna H. Ryan, MD; Christopher D. Still, DO

The Intersection of Sleep and Cardiometabolic Risk: Important Connections and Practice Implications
Sirimon Reutrakul, MD

Challenging Obesity Cases & Panel Discussion
Moderator: Robert H. Eckel, MD
Panelists: Mercedes Carnethon, PhD; Jane Reusch, MD; Donna H. Ryan, MD; Sirimon Reutrakul, MD; Christopher D. Still, DO

Dyslipidemia/Atherosclerosis/Thrombosis

Low-Dose Colchicine (0.5 mg) for Chronic Atherosclerosis as an Adjunct to Statin Therapy
Paul Ridker, MD

Statin Intolerance: How To Assess and Practical Pearls for Addressing It
Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC

Hypertriglyceridemia: Trials, Tribulations, and Transition to Clinical Practice
Michael D. Shapiro, DO

Challenging Lipid Management Cases & Panel Discussion
Moderator: Christie M. Ballantyne, MD
Panelists: Robert H. Eckel, MD; Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC; Patrick M. Moriarty, MD; Pamela B. Morris, MD; Paul Ridker, MD; Michael D. Shapiro, DO

Diabetes

Where Are We With Respect to Glycemic Control in T2D - A 2023 Update
Vanita R. Aroda, MD

Early Treatment Intensification in Type 2 Diabetes
Juan P. Frias, MD

Heterogeneity of Diabetes
Anne L. Peters, MD

Optimizing Glycemic Control with Commonly-Available Combination Therapies: Tips and Pearls
Athena Philis-Tsimikas, MD

How Social Determinants of Health Impact Type 2 Diabetes Treatment
Shivani Agarwal, MD, MPH

Challenging Diabetes Management Cases & Panel Discussion
Moderator: Anne L. Peters, MD
Panelists: Shivani Agarwal, MD, MPH; Vanita R. Aroda, MD; Juan P. Frias, MD; Athena Philis-Tsimikas, MD

CardioRenal

Tackling the Disproportionate Burden of Resistant Hypertension in Black Adults: Perspectives & Advances
Supported by an independent medical educational grant from Medtronic.
Keith C. Ferdinand, MD; Debbie Cohen, MD

Sleep and Hypertension: A Two-Way Street
Virend K. Somers, MD, PhD

The Role of Steroidal and Non-Steroidal MRAs in Cardiorenal Risk Reduction
Ajay K. Singh, MBBS, FRCP, MBA

Which Patients Should Get SGLT2is and GLP-1 RAs for Cardiorenal Risk Reduction? Interpreting Guidelines and Clinical Trials to Patient Care
Pam R. Taub, MD, FACC, FASPC

The Continuum of Heart Failure
Alanna A. Morris MD, MSc, FHFSA, FACC, FAHA

Challenging Cardiorenal Cases & Expert Panel Discussion
Moderator: Moderator: Keith C. Ferdinand, MD
Panelists: Debbie Cohen, MD; Alanna Morris MD, MSc, FHFSA, FACC, FAHA; Ajay K. Singh, MBBS, FRCP, MBA; Virend K. Somers, MD, PhD; Pam R. Taub, MD, FACC, FASPC

CMHC Chairpersons 

  • George L. Bakris, MD | Director, Am Heart Assoc. Comprehensive Hypertension Center, University of Chicago Medicine

  • Christie M. Ballantyne, MD | Professor of Medicine, Baylor College of Medicine

  • Robert H. Eckel, MD | Professor of Medicine, Emeritus, University of Colorado Anschutz Medical Campus

  • Anne L. Peters, MD | Director, Clinical Diabetes Program, Keck School of Medicine of USC

Senior Planning Committee

  • Deepak L. Bhatt, MD | Executive Director of Interventional Cardiovascular Programs, Brigham and Women’s Hospital Heart & Vascular Center

  • Keith C. Ferdinand, MD, FACC, FAHA | Professor of Medicine, Tulane University School of Medicine

  • Pam R. Taub, MD, FACC | Professor of Medicine, UC San Diego

  • Erin D. Michos, MD, MHS | Director of Women's Cardiovascular Health, Johns Hopkins University School of Medicine

Faculty 

  • Seth Martin, MD, MHS

  • Patrick Dunn, PhD

  • Tiffany Powell-Wiley, MD, MPH

  • Athena Philis-Tsimikas, MD

  • Martin S. Hagger, PhD

  • Grazia Aleppo, MD, FACE, FACP

  • Viral Shah, MD

  • Daichi Shimbo, MD

  • Mohamed B. Elshazly, MD, MBEE, FACC

  • Francoise Marvel, MD

  • Yvonne Commodore-Mensah, PhD, MHS, RN

  • Eric D. Peterson, MD, MPH

  • A. Enrique Caballero, MD

  • Mercedes Carnethon, PhD

  • Jane Reusch, MD

  • Donna H. Ryan, MD

  • Christopher D. Still, DO

  • Sirimon Reutrakul, MD

  • Paul Ridker, MD

  • Michael D. Shapiro, DO

  • Patrick M. Moriarty, MD

  • Pamela B. Morris, MD

  • Vanita R. Aroda, MD 

  • Juan P. Frias, MD 

  • Shivani Agarwal, MD, MPH

  • Debbie Cohen, MD

  • Virend K. Somers, MD, PhD

  • Ajay K. Singh, MBBS, FRCP, MBA

  • Alanna A. Morris, MD, MSc 

Disclosure link: 
Faculty Disclosures

ESTIMATED TIME TO COMPLETE ACTIVITY
19.25 hours

JOINT PROVIDERSHIP STATEMENT

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Cardiometabolic Health Congress (CMHC).  PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CONTINUING EDUCATION
PACE designates this enduring activity for a maximum of 19.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSING CONTINUING EDUCATION
The maximum number of hours awarded for this Continuing Nursing Education activity is 19.25 contact hours.

Pharmacotherapy contact hours for Advance Practice Registered Nurses will be designated on your certificate.

PHARMACY CONTINUING EDUCATION
PACE designates this continuing education activity for 19.25 contact hour(s) (1.925 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number - JA4008073-9999-23-306-H01-P. Type of activity: Application

DIETITIAN CONTINUING EDUCATION
This program offers 19.25 CPEUs for dietitians.

DISCLOSURES
Information on planner and faculty disclosures can be found PDF iconhere..

DISCLOSURE OF CONFLICT OF INTEREST
PACE requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

METHOD OF PARTICIPATION & REQUEST FOR CREDIT 
There is a registration fee for this activity (if you were a live attendee please refer to the below note). Registration can be found here. Once registration is complete, you will receive a confirmation email with an access code and link back to this course.

If you attended the 2023 annual meeting, please reach out to info@cardiometabolichealth.org and we will provide you with complimentary access code to this activity.

During the period December 5, 2023 through December 5, 2024, participants must read the learning objectives and faculty disclosures, study the educational activity and complete the evaluation.  Upon completing, your certificate will be available for print. For questions about receiving certificates, please contact us at CMHC_Eval@cardiometabolichealth.org.

For additional information about the accreditation of this activity, please visit https://partnersed.com

For Pharmacists: Please complete the evaluation instructions above. Upon registering and completing the activity evaluation, your transcript information will be sent to the NABP CPE Monitor Service within 4-6 weeks.

Available Credit

  • 19.25 ACPE Pharmacy
  • 19.25 AMA PRA Category 1 Credit™
  • 19.25 ANCC
  • 19.25 CDE
  • 19.25 Participation
Please login or register to take this course.

There is a registration fee for this activity (if you were a live attendee please refer to the below note). Registration can be found here. Once registration is complete, you will receive a confirmation email with an access code and link back to this course.

If you attended the 2023 annual meeting, please reach out to info@cardiometabolichealth.org and we will provide you with complimentary access code to this activity.

Required Hardware/software

A computer with an internet connection

Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser

Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.